Observational analysis uncovered links between fmo mutations and lifespan extension in C. elegans, suggesting metabolic insights for ageing.
Abstract Introduction: Flavin-Containing Monooxygenases (FMO) are widely conserved, xenobiotic-detoxifying enzymes whose additional endogenous functions have been revealed in recent studies. Those roles include the regulation of longevity in the model nematode Caenorhabtidis elegans. Objectives: The purpose of this study was to compare aspects of the phenotypes of C. elegans worms with mutations in all fmogenes, particularly focusing on the metabolome and its relationship with lifespan-extension and the worm life cycle. Methods: NMR Spectroscopic analysis of the extracts of metabolites from C. elegans worms of different ages and fmo genotypes was used to compare metabolite profiles of C. elegansworms and determine how these changed with genotype and ageing. Results: Loss of both fmo-4 and fmo-3 and over-expression of fmo-2, resulted in increased levels of tryptophan in the metabolome, which correlated with an extended lifespan in these mutants. Loss of fmo-4 also led to decreased embryo hatching, along with increased sensitivity to bleach during sterilisation protocols. In contrast, in the extended lifespan fmo-1 knockout worm, the metabolome did not reveal any significant metabolite changes and therefore lifespan effects may occur through another mechanism, or hidden metabolic changes. Conclusion: Genetic interventions coupled with metabolome profiling in C. elegans can provide insights into biological mechanisms in ageing that might lead to strategies for healthy lifespan extension in human old age.
No takes yet. Share an insight, caveat, or question.
Said et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: